May 14, 2025

Juror Attitudes Toward High-Tech Companies in Patent Litigation

In a changing patent litigation landscape, the DOAR Research Center studied how jurors view high-tech companies across key venues. While jurors often view technology companies favorably, skepticism remains around issues such as market power and fairness. The research shows that venue alone no longer drives risk. Instead, juror demographics and political orientation play a larger role, highlighting the need for precise jury selection and tailored trial strategies.

Read Now

Jun 24, 2025

Public Attitudes Toward White-Collar Crime in the Aftermath of the Presidential Election

Following the 2024 presidential election, the DOAR Research Center conducted a national survey revealing a shift in how jurors view white-collar cases. Traditional assumptions about defense- or prosecution-leaning jurors no longer hold. Instead, political identity, combined with demographic factors and trust in institutions, now plays a central role in how jurors evaluate corporate defendants, prosecutors, and enforcement priorities. The findings have important implications for jury selection and trial strategy in an increasingly polarized courtroom.

By Ellen Brickman, Ph.D.

Read Now

Research Center: Life Sciences

Report cover showing a black and white photo of a pill bottle and a glass of water on a table with a shadow being cast. The pill bottle has a copper tint to it.

May 14, 2024

A National Study of Community Attitudes Toward Pharmaceutical Companies

Amid growing concern over drug pricing and the opioid crisis, the DOAR Research Center studied public attitudes toward pharmaceutical companies. While overall views are more favorable than expected, most jurors believe high drug prices are driven by profit motives. Attitudes vary based on personal experience, income, and political identity, shaping how jurors assess corporate responsibility, pricing arguments, and witness credibility in pharmaceutical litigation.

Read Now